Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 225 results for "Suboxone Tablets"

Court Allows Product Hopping Claims to Proceed in Suboxone Lit...

Weve previously discussed antitrust claims related to product hopping—allegations that pharmaceutical manufacturers have reformulated or otherwise altered their products to prevent automatic generic substitution. Earlier this week, the district ... JD Supra, 2 weeks ago

INDIVIOR PLC Admission to the Official List and to Trading on the London Stock Exchange

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.THIS ANNOUNCEMENT IS NOT A PROSPECTUS BUT AN AND INVESTORS ...
 Wall Street Business Network4 days ago Admission to the Official List and to Trading  TrustNet4 days ago
[x]  

Indivior PLC Assigned #B# Corporate Credit Senior Secured Debt Rated #B# (Recovery Rating:

BOSTON (Standard & Poor's) Dec. 22, 2014--Standard & Poor's Ratings Servicestoday assigned its 'B' corporate credit rating to U.K.-based Indivior PLC. Atthe same time, we assigned a 'B' issue-level rating to both the senior securedrevolving credit ...
 Newswit.com4 days ago

OREXO : Reports Results from the ISTART Study

Orexo US recently reported results from the ISTART/006 study. According to a release from the company, in the study, Zubsolv sublingual tablet demonstrated comparable patient retention in treatment at day 15 versus Suboxone film. ZUBSOLV also ...
 4 Traders6 days ago OREXO : Releases Results from the ISTART Study  4 Traders2 weeks ago Orexo presents new Ph III data for Zubsolv  Pharma Letter2 weeks ago
Pink Sheets

Positive Phase 3 Trial Results Announced for Zubsolv

Share this article: Orexo announced positive results from the ISTART study on Zubsolv (buprenorphine and naloxone) sublingual tablets. The ISTART study was a PHASE 3 randomized, multicenter, non-inferiority trial that studied the ...
 Monthly Prescribing Reference2 weeks ago Orexo announces positive results from ISTART/006 study  News-Medical.Net2 weeks ago Orexo AB (ORXOY: OTCQX International) | Orexo Features Positive Results from the ISTART Study at the 2014 AAAP Meeting  Pink Sheets2 weeks ago Orexo Features Positive Results from the ISTART Study at the 2014 AAAP Meeting  Franklin Credit Management Corporation2 weeks ago
[x]  

Could iPads Be the Answer to Curbing Drug Abuse?

A November 25 article from the includes a fascinating study from a local university, which is investigating whether or not the humble iPad could be used to prevent prescription drug abuse an ongoing problem across the US. Academics at the ...
 Digital Journal3 weeks ago
[x]  

Reckitt Benckiser launches pharma spin-off

Reckitt Benckiser is following a healthcare trend by spinning off its pharmaceutical business, but in Reckitt's case this is currently very much a one-product business, with almost all its revenues coming from a heroine substitute, Suboxone. In ...
 EIU3 weeks ago Proposed Demerger of the RB Pharma business  London Stock Exchange1 month ago Reckitt Benckiser to spin off its pharmaceuticals business  Manufacturing Chemist1 month ago
This is Money

Reckitt offices raided by US officials [Daily Mail, London :: ]

Nov. 18--The US Attorney has raided the offices of Nurofen and Durex owner Reckitt Benckiser according to documents filed ahead of the pounds sterling 2.5bn float of the firm's pharmaceutical division. The RPB division, which makes a heroin ...
 BusinessWeek1 month ago Reckitt Benckiser reveals Virginia office was raided by US officials in 2013  This is Money1 month ago
Interactive Investor

Reckitt Benckiser shareholders should sell new pharma shares

Questor thinks that when Reckitt Benckiser (Xetra: A0M1W6 - news) gives its investors new shares in the demerged pharmaceutical unit they should be sold. Reckitt Benckiser ÂŁ53.20-5p Questor says HOLD Household goods giant Reckitt Benckiser ...
 Yahoo! UK and Ireland1 month ago Reckitt Benckiser drug spin-off confirmed  Interactive Investor1 month ago Reckitt Benckiser : Pharma Business To Be Demerged By Christmas (UPDATE)  4 Traders1 month ago UPDATE: Reckitt Benckiser Pharma Business To Be Demerged By Christmas  London South East1 month ago

RECKITT BENCKISER : Announces Details of Indivior Float -- 2nd Update

By Ian Walker LONDON-- Reckitt Benckiser Group PLC, the U.K. consumer-goods maker, said it would list its pharmaceutical unit as a separate company on the London Stock Exchange on Dec. 23. Existing shareholders are to receive one share in the ...
 4 Traders1 month ago Reckitt Benckiser : Details Indivior Float -- Update  4 Traders1 month ago Reckitt Benckiser Announces Details of Indivior Float -- 2nd Update  ADVFN India1 month ago Reckitt Benckiser Details Indivior Float -- Update  ADVFN India1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less